These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11719862)

  • 21. ACE inhibitors, angiotensin receptor antagonists and bradykinin.
    Schachter M
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):27-9. PubMed ID: 11967793
    [No Abstract]   [Full Text] [Related]  

  • 22. [Nephrology 2005/2006. Recent clinical studies and developments in science].
    Floege J
    Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1445-8. PubMed ID: 16794972
    [No Abstract]   [Full Text] [Related]  

  • 23. Blood pressure and renal outcomes in patients with kidney infarction and hypertension.
    Paris B; Bobrie G; Rossignol P; Le Coz S; Chedid A; Plouin PF
    J Hypertens; 2006 Aug; 24(8):1649-54. PubMed ID: 16877969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of the renin-angiotensin-aldosterone system to prevent ischemic and atherothrombotic events.
    Papademetriou V
    Am Heart J; 2009 Jun; 157(6 Suppl):S24-30. PubMed ID: 19450721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Indications for associated renal revascularization].
    Pozzi M; Locatelli F
    Minerva Cardioangiol; 2002 Oct; 50(5 Suppl 1):22-5. PubMed ID: 12629478
    [No Abstract]   [Full Text] [Related]  

  • 26. [High risk arterial hypertension: the role of angiotensin II receptor blockers].
    Fomin VV; Moiseev SV; Mukhin NA
    Ter Arkh; 2007; 79(10):86-91. PubMed ID: 18154154
    [No Abstract]   [Full Text] [Related]  

  • 27. [Renovascular arterial hypertension: new therapeutic approaches].
    Mazza F; Contiello V; Ciappa G; Ferro G
    Minerva Cardioangiol; 1986 Nov; 34(11):735-9. PubMed ID: 2949161
    [No Abstract]   [Full Text] [Related]  

  • 28. Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, or both in chronic heart failure.
    Young JB
    Heart Fail Clin; 2005 Apr; 1(1):39-47. PubMed ID: 17386832
    [No Abstract]   [Full Text] [Related]  

  • 29. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin receptor blockers do not have an advantage over angiotensin-converting inhibitors [corrected].
    Harman-Boehm I
    Isr Med Assoc J; 2004 May; 6(5):296-8. PubMed ID: 15151373
    [No Abstract]   [Full Text] [Related]  

  • 31. The practical aspects of combination therapy with angiotensin receptor blockers and angiotensin-converting enzyme inhibitors.
    Sica DA
    J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):66-71. PubMed ID: 12228845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Standpoint on the use of angiotensin receptor blockers in the treatment of hypertension].
    Stern N; Grossman E; ; ; ;
    Harefuah; 2003 Apr; 142(4):309-11, 315. PubMed ID: 12754885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin and its inhibition: a nephrologist point of view.
    Kalra V; Agarwal SK; Wani M
    J Assoc Physicians India; 2002 Oct; 50():1270-80. PubMed ID: 12568213
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
    Crook ED; Preddie DC
    Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress in the development of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Singh RK; Barker S
    Curr Opin Investig Drugs; 2005 Mar; 6(3):269-74. PubMed ID: 15816503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
    Ghanem FA; Movahed A
    Rev Cardiovasc Med; 2005; 6(4):206-13. PubMed ID: 16379016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A 57-year-old patient with refractory hypertension and chest pain].
    Höfling B; Ingrisch H; Kleinhans E; Ludwig B; Erdmann E
    Internist (Berl); 1984 Nov; 25(11):705-8. PubMed ID: 6239834
    [No Abstract]   [Full Text] [Related]  

  • 38. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.
    Quan A
    Early Hum Dev; 2006 Jan; 82(1):23-8. PubMed ID: 16427219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RAS inhibition in hypertension.
    Ibrahim MM
    J Hum Hypertens; 2006 Feb; 20(2):101-8. PubMed ID: 16397519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [ACE-inhibitors, AT1 receptor antagonists and diastolic dysfunction].
    Metra M; Nodari S; Bordonali T; Cagnazzi E; Boldi E; Dei Cas L
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):53-8. PubMed ID: 12497882
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.